Evidence-Based Review of the Management of Cancers of the Gastroesophageal Junction
Department of Cardiothoracic Surgery, Boston University School of Medicine, 88 East Newton Street, Robinson B-402, Boston, MA 02118, USA.Thoracic Surgery Clinics (Impact Factor: 0.77). 02/2012; 22(1):109-21, vii-viii. DOI: 10.1016/j.thorsurg.2011.09.001
The management of localized esophageal cancer has traditionally been surgical resection; yet, despite improvements in outcomes and techniques, survival for patients with esophageal cancer, especially those with evidence of nodal involvement, remains poor. In this article, we have used an evidence-based approach to define optimal therapy based on clinical stage for esophageal cancer. We review the currently available evidence supporting the use of neoadjuvant and adjuvant therapies for locally advanced esophageal cancer. Additionally, we review the evidence supporting the role of endoscopic therapies, rather than resection, for early-stage esophageal cancer.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.